Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Apr;38(4):719–723. doi: 10.1128/aac.38.4.719

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.

T Shaw 1, P Amor 1, G Civitico 1, M Boyd 1, S Locarnini 1
PMCID: PMC284531  PMID: 8031035

Abstract

The in vitro antihepadnavirus activities of the purine nucleoside analogs ganciclovir (9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine) and penciclovir [9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; BRL 39123] were compared in primary duck hepatocyte cultures congenitally infected with the duck hepatitis B virus (DHBV). Both compounds inhibited DHBV DNA replication to a comparable extent during continuous short-term treatment of the cultures. However penciclovir was more active both during longer-term continuous treatment (50% inhibitory concentrations: penciclovir, 0.7 +/- 0.1 microM; ganciclovir, 4.0 +/- 0.2 microM) and in washout experiments (50% inhibitory concentrations: penciclovir, 3.0 +/- 0.4 microM; ganciclovir, 46 +/- 1.5 microM) designed to compare the persistence of inhibitory activity after removal of the extracellular compound. The effects on viral protein synthesis were similar to the effects on viral DNA replication. These data suggest that penciclovir or its oral form, famciclovir, may have clinical utility in the treatment of chronic hepatitis B virus infection.

Full text

PDF
719

Images in this article

721Image
on p.721

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahluwalia G., Cooney D. A., Bondoc L. L., Jr, Currens M. J., Ford H., Johns D. G., Mitsuya H., Fridland A. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine. Biochem Biophys Res Commun. 1990 Sep 28;171(3):1297–1303. doi: 10.1016/0006-291x(90)90827-a. [DOI] [PubMed] [Google Scholar]
  2. Angus P., Richards M., Bowden S., Ireton J., Sinclair R., Jones R., Locarnini S. Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection. J Gastroenterol Hepatol. 1993 Jul-Aug;8(4):353–357. doi: 10.1111/j.1440-1746.1993.tb01527.x. [DOI] [PubMed] [Google Scholar]
  3. Ashton W. T., Karkas J. D., Field A. K., Tolman R. L. Activation by thymidine kinase and potent antiherpetic activity of 2'-nor-2'-deoxyguanosine (2'NDG). Biochem Biophys Res Commun. 1982 Oct 29;108(4):1716–1721. doi: 10.1016/s0006-291x(82)80109-5. [DOI] [PubMed] [Google Scholar]
  4. Balzarini J., Lee C. K., Herdewijn P., De Clercq E. Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus. J Biol Chem. 1991 Nov 15;266(32):21509–21514. [PubMed] [Google Scholar]
  5. Bishop N., Civitico G., Wang Y. Y., Guo K. J., Birch C., Gust I., Locarnini S. Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model. J Med Virol. 1990 Jun;31(2):82–89. doi: 10.1002/jmv.1890310204. [DOI] [PubMed] [Google Scholar]
  6. Boyd M. R., Bacon T. H., Sutton D. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals. Antimicrob Agents Chemother. 1988 Mar;32(3):358–363. doi: 10.1128/aac.32.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Civitico G., Wang Y. Y., Luscombe C., Bishop N., Tachedjian G., Gust I., Locarnini S. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds. J Med Virol. 1990 Jun;31(2):90–97. doi: 10.1002/jmv.1890310205. [DOI] [PubMed] [Google Scholar]
  8. Earnshaw D. L., Bacon T. H., Darlison S. J., Edmonds K., Perkins R. M., Vere Hodge R. A. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother. 1992 Dec;36(12):2747–2757. doi: 10.1128/aac.36.12.2747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ellims P. H., Van der Weyden M. B. Human liver thymidine kinase. Purification and some properties of the enzyme. J Biol Chem. 1980 Dec 10;255(23):11290–11295. [PubMed] [Google Scholar]
  10. Fautz R., Husein B., Hechenberger C. Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutat Res. 1991 Oct;253(2):173–179. doi: 10.1016/0165-1161(91)90130-z. [DOI] [PubMed] [Google Scholar]
  11. Hirota K., Sherker A. H., Omata M., Yokosuka O., Okuda K. Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection. Hepatology. 1987 Jan-Feb;7(1):24–28. doi: 10.1002/hep.1840070107. [DOI] [PubMed] [Google Scholar]
  12. Itoh R. IMP-GMP 5'-nucleotidase. Comp Biochem Physiol B. 1993 May;105(1):13–19. doi: 10.1016/0305-0491(93)90163-y. [DOI] [PubMed] [Google Scholar]
  13. Jansson O., Bohman C., Munch-Petersen B., Eriksson S. Mammalian thymidine kinase 2. Direct photoaffinity labeling with [32P]dTTP of the enzyme from spleen, liver, heart and brain. Eur J Biochem. 1992 Jun 1;206(2):485–490. doi: 10.1111/j.1432-1033.1992.tb16951.x. [DOI] [PubMed] [Google Scholar]
  14. Johnson M. A., Fridland A. Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells. Mol Pharmacol. 1989 Aug;36(2):291–295. [PubMed] [Google Scholar]
  15. Keller P. M., McKee S. A., Fyfe J. A. Cytoplasmic 5'-nucleotidase catalyzes acyclovir phosphorylation. J Biol Chem. 1985 Jul 25;260(15):8664–8667. [PubMed] [Google Scholar]
  16. Lee B., Luo W. X., Suzuki S., Robins M. J., Tyrrell D. L. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother. 1989 Mar;33(3):336–339. doi: 10.1128/aac.33.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Littler E., Stuart A. D., Chee M. S. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature. 1992 Jul 9;358(6382):160–162. doi: 10.1038/358160a0. [DOI] [PubMed] [Google Scholar]
  18. Locarnini S. Design of new anti-viral agents for chronic hepatitis B virus infection. J Gastroenterol Hepatol. 1991;6 (Suppl 1):18–22. doi: 10.1111/j.1440-1746.1991.tb01161.x. [DOI] [PubMed] [Google Scholar]
  19. Locarnini S., Guo K., Lucas R., Gust I. Inhibition of HBV DNA replication by ganciclovir in patients with AIDS. Lancet. 1989 Nov 18;2(8673):1225–1226. doi: 10.1016/s0140-6736(89)91839-4. [DOI] [PubMed] [Google Scholar]
  20. Marion P. L. Development of antiviral therapy for chronic infection with hepatitis B virus. Curr Top Microbiol Immunol. 1991;168:167–183. doi: 10.1007/978-3-642-76015-0_8. [DOI] [PubMed] [Google Scholar]
  21. Niu J., Wang Y., Dixon R., Bowden S., Qiao M., Einck L., Locarnini S. The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus. Antiviral Res. 1993 Jun;21(2):155–171. doi: 10.1016/0166-3542(93)90051-j. [DOI] [PubMed] [Google Scholar]
  22. Seeger C., Summers J., Mason W. S. Viral DNA synthesis. Curr Top Microbiol Immunol. 1991;168:41–60. doi: 10.1007/978-3-642-76015-0_3. [DOI] [PubMed] [Google Scholar]
  23. Smee D. F., Knight S. S., Duke A. E., Robinson W. S., Matthews T. R., Marion P. L. Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase. Antimicrob Agents Chemother. 1985 Feb;27(2):277–279. doi: 10.1128/aac.27.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sullivan V., Talarico C. L., Stanat S. C., Davis M., Coen D. M., Biron K. K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 1992 Jul 9;358(6382):162–164. doi: 10.1038/358162a0. [DOI] [PubMed] [Google Scholar]
  25. Suzuki S., Lee B., Luo W., Tovell D., Robins M. J., Tyrrell D. L. Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides. Biochem Biophys Res Commun. 1988 Nov 15;156(3):1144–1151. doi: 10.1016/s0006-291x(88)80752-6. [DOI] [PubMed] [Google Scholar]
  26. Tuttleman J. S., Pugh J. C., Summers J. W. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol. 1986 Apr;58(1):17–25. doi: 10.1128/jvi.58.1.17-25.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vere Hodge R. A., Sutton D., Boyd M. R., Harnden M. R., Jarvest R. L. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]. Antimicrob Agents Chemother. 1989 Oct;33(10):1765–1773. doi: 10.1128/aac.33.10.1765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yokota T., Konno K., Chonan E., Mochizuki S., Kojima K., Shigeta S., de Clercq E. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro. Antimicrob Agents Chemother. 1990 Jul;34(7):1326–1330. doi: 10.1128/aac.34.7.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES